Blackstone Inc. - BX STOCK NEWS

Byron R. Wien and Joe Zidle from Blackstone have released the Ten Surprises of 2023, highlighting potential economic and market shifts. Key surprises include a competitive presidential nomination race, a hawkish Fed potentially leading to a mild recession, and a recovery in the market by mid-year. Other notable points are China's growth efforts, the U.S. becoming a leading oil producer, and continued challenges in Ukraine. Blackstone, managing $951 billion in assets, aims to create positive economic impact and long-term value for investors and communities.

Blackstone (NYSE: BX) and UC Investments have announced a significant long-term strategic partnership, with UC Investments committing $4 billion to acquire Class I common shares of Blackstone Real Estate Income Trust (BREIT). Blackstone will contribute $1 billion of its existing BREIT holdings in this venture. This investment is expected to enhance BREIT’s balance sheet flexibility and capital, providing an 11.25% minimum annualized net return for UC Investments over a six-year hold period. BREIT has delivered a 12.7% annualized return since inception.

Blackstone Private Credit Fund (BCRED) has announced an increase in its monthly distribution from $0.1900 to $0.2100 per share, representing a 10.2% annualized yield based on an October NAV of $24.60. This adjustment will take effect for the December 2022 distribution, with a record date of December 30, 2022, and payment expected around January 27, 2023. The increase is attributed to rising earnings power due to higher interest rates and an advantageous portfolio structure.

VICI Properties has signed an agreement to acquire BREIT's 49.9% interest in the joint venture owning MGM Grand Las Vegas and Mandalay Bay for approximately $1.27 billion. This acquisition also involves VICI assuming BREIT’s share of property-level debt of $3 billion, maturing in 2032. The properties are subject to a triple-net lease with MGM Resorts, yielding annual rents of $310 million. The deal is expected to be accretive to VICI's AFFO per share and is anticipated to close in early 2023.

Blackstone (NYSE:BX) announced that Chairman and CEO Stephen Schwarzman will present at the Goldman Sachs 2022 US Financial Services Conference on December 7, 2022, at 12:20 PM ET. Investors can view the presentation live via webcast on Blackstone's website, with a replay available afterward. Blackstone, the world's largest alternative asset manager, oversees $951 billion in assets under management across various investment vehicles.

Blackstone (NYSE: BX) has successfully completed an offering of $600 million in 5.900% senior notes due 2027 and $900 million in 6.200% senior notes due 2033 through its subsidiary, Blackstone Holdings Finance Co. The notes are guaranteed by Blackstone and its indirect subsidiaries. Proceeds from the offering will be used for general corporate purposes. The notes were sold to qualified institutional buyers under Rule 144A and Regulation S without registration under the Securities Act of 1933.

Blackstone (NYSE: BX) has announced the pricing of a $600 million offering of 5.900% senior notes due 2027 and $900 million of 6.200% senior notes due 2033. These notes will be fully guaranteed by Blackstone and its subsidiaries. The proceeds from this offering are intended for general corporate purposes. The notes will be sold to qualified institutional buyers under Rule 144A and Regulation S, though they are not registered under the Securities Act of 1933 and cannot be sold in the U.S. without registration or exemption.

Blackstone (NYSE: BX) announced plans to offer senior notes through its subsidiary, Blackstone Holdings Finance Co. L.L.C. The notes will be guaranteed by Blackstone and its indirect subsidiaries. Proceeds from the offering will be used for general corporate purposes. The notes are intended for sale to qualified institutional buyers under Rule 144A in the U.S. and outside the U.S. under Regulation S. These notes have not been registered under the Securities Act of 1933 and cannot be sold without registration or an exemption.

PTC Therapeutics has entered a strategic financing collaboration with Blackstone, securing up to $500 million in funding to enhance its product pipeline and business development. This includes $350 million in low-cost capital at the close. The funds will help accelerate PTC's mission to deliver transformative medicines, with a goal of launching one therapy every 2-3 years. Blackstone's investment will be collateralized by PTC's existing products, including Translarna™ and Upstaza®. The collaboration aims to optimize capital structure and support new medicines.